MedPath

浙江博崤生物制药有限公司

Ownership
-
Established
2020-08-24
Employees
-
Market Cap
-
Website
www.ssh-biopharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Ropivacaine Hydrochloride Injection

Product Name
盐酸罗哌卡因注射液
Approval Number
国药准字H20249833
Approval Date
Dec 25, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.